Annual Accounts Payable
$4.15 M
+$2.38 M+134.67%
December 31, 2023
Summary
- As of February 8, 2025, JSPR annual accounts payable is $4.15 million, with the most recent change of +$2.38 million (+134.67%) on December 31, 2023.
- During the last 3 years, JSPR annual accounts payable has risen by +$2.73 million (+192.80%).
- JSPR annual accounts payable is now at all-time high.
Performance
JSPR Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$3.09 M
+$122.00 K+4.12%
September 30, 2024
Summary
- As of February 8, 2025, JSPR quarterly accounts payable is $3.09 million, with the most recent change of +$122.00 thousand (+4.12%) on September 30, 2024.
- Over the past year, JSPR quarterly accounts payable has dropped by -$170.00 thousand (-5.22%).
- JSPR quarterly accounts payable is now -25.62% below its all-time high of $4.15 million, reached on December 31, 2023.
Performance
JSPR Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
JSPR Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +134.7% | -5.2% |
| 3 y3 years | +192.8% | -5.2% |
| 5 y5 years | +192.8% | -5.2% |
JSPR Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +134.7% | -25.6% | +110.5% |
| 5 y | 5-year | at high | +192.8% | -25.6% | +117.8% |
| alltime | all time | at high | +192.8% | -25.6% | +117.8% |
Jasper Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $3.09 M(+4.1%) |
| Jun 2024 | - | $2.96 M(+24.0%) |
| Mar 2024 | - | $2.39 M(-42.4%) |
| Dec 2023 | $4.15 M(+134.7%) | $4.15 M(+27.4%) |
| Sep 2023 | - | $3.26 M(+105.9%) |
| Jun 2023 | - | $1.58 M(-58.9%) |
| Mar 2023 | - | $3.85 M(+117.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $1.77 M(-54.9%) | $1.77 M(-43.3%) |
| Sep 2022 | - | $3.12 M(+4.0%) |
| Jun 2022 | - | $3.00 M(+104.4%) |
| Mar 2022 | - | $1.47 M(-62.6%) |
| Dec 2021 | $3.92 M(+176.6%) | $3.92 M(+74.4%) |
| Sep 2021 | - | $2.25 M(+58.6%) |
| Dec 2020 | $1.42 M | $1.42 M |
FAQ
- What is Jasper Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Jasper Therapeutics?
- What is Jasper Therapeutics annual accounts payable year-on-year change?
- What is Jasper Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Jasper Therapeutics?
- What is Jasper Therapeutics quarterly accounts payable year-on-year change?
What is Jasper Therapeutics annual accounts payable?
The current annual accounts payable of JSPR is $4.15 M
What is the all time high annual accounts payable for Jasper Therapeutics?
Jasper Therapeutics all-time high annual accounts payable is $4.15 M
What is Jasper Therapeutics annual accounts payable year-on-year change?
Over the past year, JSPR annual accounts payable has changed by +$2.38 M (+134.67%)
What is Jasper Therapeutics quarterly accounts payable?
The current quarterly accounts payable of JSPR is $3.09 M
What is the all time high quarterly accounts payable for Jasper Therapeutics?
Jasper Therapeutics all-time high quarterly accounts payable is $4.15 M
What is Jasper Therapeutics quarterly accounts payable year-on-year change?
Over the past year, JSPR quarterly accounts payable has changed by -$170.00 K (-5.22%)